Kongressberichte & Archiv

SG-PRO 2015: 6. Interdisziplinäres Prostatakarzinomsymposium

II Das nodal positive Prostatakarzinom

II Das nodal positive Prostatakarzinom - Moderation: G. Thalmann, L. Plasswilm

Beurteilung und operative Behandlung: D. Weckermann, Augsburg

Beurteilung und operative Behandlung: D. Weckermann, Augsburg

Vorgehen aus radioonkologischer Sicht: T. Wiegel, Ulm

Vorgehen aus radioonkologischer Sicht: T. Wiegel, Ulm

News

First-line NIVO + CT vs CT alone for advanced gastric, gastro-oesophageal junction, & oesophageal adenocarcinoma (CheckMate 649): a new standard

07-07-2021 12:45
Weiterlesen ...
Blood test for early detection of cancer: final study results support screening use. Test can detect over 50 types of cancer, often before symptoms show

24-06-2021 23:01
Weiterlesen ...
Swissmedic Approves TEPMETKO® a Once-Daily Targeted Therapy for NSCLC with a METex14 Skipping Mutation1

23-06-2021 11:32
Weiterlesen ...
Isatuximab + carfilzomib–dexamethasone: a new standard of care for R/R MM

21-06-2021 08:58
Weiterlesen ...
Lehrvideo zur Entfernung von Bauchspeicheldrüsentumoren mittels Robotik

16-04-2021 08:42
Weiterlesen ...
New Standard of Care: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

03-04-2021 08:40
Weiterlesen ...
Longer Follow-Up Continues to Support First-Line Pembrolizumab Plus Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer

26-03-2021 09:58
Go to the ELCC/ESMO 2021 PRESS RELEASE
SECOND DRUG TARGETING KRAS G12C SHOWS BENEFIT IN MUTATED NON-SMALL-CELL LUNG CANCER

25-03-2021 17:15
Go to the ELCC/ESMO 2021 PRESS RELEASE
ASCO Remembers Breast Cancer Drug Development Pioneer Dr. José Baselga

24-03-2021 09:47
ASCO and the oncology community are deeply saddened by the passing of José Baselga, MD, PhD, FASCO, on March 21, 2021, at age 61. Dr. Baselga died of Creutzfeldt-Jakob disease, a rare fatal neurodegenerative disorder, according to his family. READ MORE